At this ACR Convergence 2025 session, clinicians discussed complex and difficult-to-diagnose pediatric cases.
Search results for: hip OA
Workforce Solutions
Three experts discussed novel and practical strategies and resources that rheumatology clinics can use to improve the referral process, screening times and patients access to care.
Complementary Medicine Meets Rheumatology: New Ways to Reduce Inflammation
At this ACR Convergence 2025 session, the speaker highlighted ways complementary and alternative medicine can be used alongside traditional medical treatments.
ARP Year in Review: Updates in Advanced Practice, Epidemiology & Rehabilitation
Three experts discussed recent notable research of interest to rheumatology professionals across a range of topics.
Secrets & Pearls of Rheumatology at ACR Convergence 2025
Two clinical diagnosticians presented their pearls of wisdom for clinical rheumatologists to take forward when managing patients from the clinics to the hospital wards.
Rheuminations: Address Ableism, Improve Care for All Patients
Ableism—discrimination against those with disabilities—distorts diagnostic reasoning & erodes patient trust. How can rheumatologists address this bias?
ACR Advocacy Update 2025, Federal & State
ACR representatives outlined its 2025 legislative priorities, including fixing the MPFS, reforming prior authorization & protecting telehealth reimbursement.
President’s Corner: Dr. Langford’s Reflections on the ACR’s 2025
Dr. Langford’s final column reflects on 2025’s advocacy, challenges & member teamwork. Click through to read the outgoing ACR president’s parting thoughts.
The Intersection of Immunology & Rheumatology
The winning case study in this year’s Thieves Market highlight a case study from Malaysia with a patient who initially presented with seronegative inflammatory arthritis but experienced recurrent infections and had a porcelain aorta.
Does High-Intensity Interval Training Lower Inflammatory Disease Activity?
Experts discuss high-intensity interval training as an underused “disease-modifying drug” for inflammatory diseases. Learn how to safely integrate it into patient treatment plans.
- « Previous Page
- 1
- …
- 34
- 35
- 36
- 37
- 38
- …
- 337
- Next Page »